Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: vinorelbine|DRUG: trastuzumab
Sponsor: Danish Breast Cancer Cooperative Group
Collaborators: Hoffmann-La Roche|Sanofi